Background For several decades, diagnoses of genital warts at genitourinary medicine
(GUM) clinics in England had been increasing. In 2008, a national human papillomavirus …

Background. Diagnoses of genital warts (GW) in genitourinary medicine (GUM) clinics have
been increasing in England for many years. In 2008, an HPV immunization program began …

Objective: This study aimed to determine if the Australian human papillomavirus (HPV)
vaccination programme has had a population impact on presentations of genital warts …

Background Australia has provided free quadrivalent human papillomavirus (HPV) vaccines
to school girls since mid-2007 and a catch-up programme in the community to women aged …

Objectives To estimate the prevalence of, and describe risk factors for, genital warts (GWs) in
the British population, following the introduction of the bivalent (human papillomavirus (HPV) …

Summary Background In Australia, the government-funded human papillomavirus (HPV)
vaccination programme was introduced in April, 2007, for girls and young women, and in …

The quadrivalent human papillomavirus (HPV) vaccine currently being delivered to
Australian women aged 12–26 years under the National HPV Vaccination Program …

Background There has been a rapid decline in the number of young heterosexuals
diagnosed with genital warts at outpatient sexual health services since the national human …

In this Review, we describe the recent epidemiology of genital warts and postulate what the
future may hold as a result of the introduction of the quadrivalent human papillomavirus …

Objectives Since the introduction of Australia's human papillomavirus vaccination program,
the management rate of genital warts in sexual health clinics and private hospitals has …